US Stock MarketDetailed Quotes
BIOLQ BIOLASE INC
- 0.009
- +0.001+9.15%
15min DelayClose Dec 4 16:00 ET
327.55KMarket Cap0.00P/E (TTM)
0.009High0.006Low180.23KVolume0.009Open0.008Pre Close1.43KTurnover0.49%Turnover Ratio0.00P/E (Static)36.60MShares0.02052wk High-0.06P/B327.53KFloat Cap0.00452wk Low--Dividend TTM36.60MShs Float0.020Historical High--Div YieldTTM35.98%Amplitude0.004Historical Low0.007Avg Price1Lot Size
BIOLASE INC Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -0.65%10.85M | -19.12%11.56M | -3.21%10.13M | 1.45%49.16M | -3.99%13.49M | -9.07%10.92M | 16.76%14.29M | 2.96%10.47M | 23.67%48.46M | 13.24%14.05M |
| Operating revenue | -0.65%10.85M | -19.12%11.56M | -3.21%10.13M | 1.45%49.16M | -3.99%13.49M | -9.07%10.92M | 16.76%14.29M | 2.96%10.47M | 23.67%48.46M | 13.24%14.05M |
| Cost of revenue | -9.85%6.47M | -14.96%6.95M | -4.70%6.8M | -0.34%32.44M | -4.68%9.97M | -24.99%7.18M | 15.14%8.17M | 31.14%7.13M | 43.66%32.55M | 39.36%10.46M |
| Gross profit | 16.98%4.38M | -24.66%4.61M | -0.03%3.34M | 5.11%16.72M | -2.00%3.52M | 53.21%3.75M | 19.00%6.12M | -29.44%3.34M | -3.74%15.91M | -26.70%3.6M |
| Operating expense | -31.79%5.08M | -21.63%7.83M | -8.88%7.86M | -15.97%34.66M | -28.47%8.6M | -26.28%7.44M | -2.02%9.99M | -3.44%8.63M | 26.36%41.25M | 30.53%12.02M |
| Selling and administrative expenses | -31.59%4.16M | -20.92%6.76M | -7.09%6.58M | -15.68%28.66M | -30.07%6.95M | -25.08%6.08M | 0.04%8.55M | -4.19%7.08M | 27.77%33.98M | 29.55%9.94M |
| -Selling and marketing expense | -15.43%2.88M | -40.31%3.69M | -26.81%3.38M | -14.92%18.44M | -34.48%4.23M | -32.07%3.4M | 14.57%6.19M | -3.99%4.62M | 41.31%21.68M | 28.40%6.45M |
| -General and administrative expense | -52.11%1.28M | 30.00%3.06M | 29.97%3.2M | -17.00%10.22M | -21.90%2.72M | -13.83%2.68M | -24.96%2.36M | -4.58%2.46M | 9.34%12.31M | 31.72%3.48M |
| Research and development costs | -32.67%917K | -25.83%1.07M | -17.07%1.28M | -17.36%6M | -20.88%1.65M | -31.18%1.36M | -12.64%1.44M | 0.19%1.55M | 20.12%7.27M | 35.41%2.09M |
| Operating profit | 81.20%-695K | 16.84%-3.22M | 14.46%-4.53M | 29.21%-17.94M | 39.77%-5.08M | 51.68%-3.7M | 23.40%-3.87M | -25.80%-5.29M | -57.22%-25.34M | -95.75%-8.43M |
| Net non-operating interest income expense | -1.17%-605K | -0.51%-586K | -7.80%-622K | 14.11%-2.36M | 58.76%-603K | -41.04%-598K | -35.58%-583K | -33.26%-577K | -23.61%-2.75M | -194.16%-1.46M |
| Non-operating interest expense | 1.17%605K | 0.51%586K | 7.80%622K | -14.11%2.36M | -58.76%603K | 41.04%598K | 35.58%583K | 33.26%577K | 23.61%2.75M | 194.16%1.46M |
| Other net income (expense) | 58.42%-116K | 369.11%1.03M | -6,690.00%-1.32M | 30.82%-303K | 196.49%338K | 15.20%-279K | -270.87%-382K | 116.67%20K | -119.49%-438K | 128.15%114K |
| Gain on sale of security | 77.52%-69K | 52.34%-112K | -580.00%-96K | 19.86%-351K | 50.00%171K | 6.69%-307K | -128.16%-235K | 116.67%20K | 3.10%-438K | 140.71%114K |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non- operating income (expenses) | -267.86%-47K | 875.51%1.14M | ---1.22M | --48K | --167K | --28K | ---147K | ---- | ---- | ---- |
| Income before tax | 69.04%-1.42M | 42.57%-2.78M | -10.57%-6.47M | 27.78%-20.6M | 45.36%-5.34M | 45.57%-4.57M | 13.44%-4.84M | -22.88%-5.85M | -77.25%-28.53M | -87.73%-9.78M |
| Income tax | -20.00%12K | -35.48%20K | 1,800.00%19K | -71.56%31K | -117.44%-15K | 188.24%15K | 34.78%31K | -94.12%1K | 67.69%109K | 19.44%86K |
| Net income | 68.88%-1.43M | 42.52%-2.8M | -10.87%-6.49M | 27.95%-20.63M | 45.99%-5.33M | 45.28%-4.59M | 13.24%-4.87M | -22.47%-5.85M | -77.21%-28.63M | -86.80%-9.86M |
| Net income continuous Operations | 68.88%-1.43M | 42.52%-2.8M | -10.87%-6.49M | 27.95%-20.63M | 45.99%-5.33M | 45.28%-4.59M | 13.24%-4.87M | -22.47%-5.85M | -77.21%-28.63M | -86.80%-9.86M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 68.88%-1.43M | 42.52%-2.8M | -10.87%-6.49M | 27.95%-20.63M | 45.99%-5.33M | 45.28%-4.59M | 13.24%-4.87M | -22.47%-5.85M | -77.21%-28.63M | -86.80%-9.86M |
| Preferred stock dividends | -100.93%-71K | 7,728.11%16.99M | 0 | 7.61M | 9.38M | -60.26%217K | 0 | |||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 88.88%-1.36M | 80.36%-2.8M | -10.87%-6.49M | -30.39%-37.62M | 45.99%-5.33M | -45.45%-12.2M | -153.88%-14.25M | -17.14%-5.85M | -72.72%-28.85M | -86.80%-9.86M |
| Basic earnings per share | 99.61%-0.04 | 99.69%-0.08 | 97.98%-0.36 | 92.96%-29.44 | 98.78%-1.5592 | 90.62%-10.35 | 71.58%-26.14 | 77.99%-17.83 | -47.69%-418.13 | -70.67%-128 |
| Diluted earnings per share | 99.61%-0.04 | 99.69%-0.08 | 97.98%-0.36 | 92.96%-29.44 | 98.78%-1.5592 | 90.62%-10.35 | 71.58%-26.14 | 77.99%-17.83 | -47.69%-418.13 | -70.67%-128 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data